| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 04/27/2000 | WO2000023619A1 Template chain reaction |
| 04/27/2000 | WO2000023618A1 Polymorphism in a tgf-beta gene correlated to osteoporosis |
| 04/27/2000 | WO2000023616A2 Method for the exponential amplification of molecular matrices |
| 04/27/2000 | WO2000023615A2 Method for extracting quantitative information relating to an influence on a cellular response |
| 04/27/2000 | WO2000023614A1 Method for monitoring proteasome inhibitor drug action |
| 04/27/2000 | WO2000023612A1 Enzymatic methods for measuring lysophospholipids and phospholipids and correlation with diseases |
| 04/27/2000 | WO2000023610A1 Method for screening compound inhibiting signal transduction of inflammatory cytokine |
| 04/27/2000 | WO2000023605A1 cDNA SEQUENCE TRANSCRIBING A mRNA CODING FOR THE TERMINAL OXYDASE ASSOCIATED WITH CAROTENOID BIOSYNTHESIS AND USES |
| 04/27/2000 | WO2000023603A2 Methods of treatment of type 2 diabetes |
| 04/27/2000 | WO2000023602A2 Regulated expression using conditional er retention domains |
| 04/27/2000 | WO2000023600A1 Materials and methods involving conditional aggregation domains |
| 04/27/2000 | WO2000023599A2 Human proteins involved in endoplasmic reticulum protein degradation |
| 04/27/2000 | WO2000023595A1 Omp85 proteins of neisseria gonorrhoeae and neisseria meningitidis, compositions containing same and methods of use thereof |
| 04/27/2000 | WO2000023588A2 G-protein coupled receptors |
| 04/27/2000 | WO2000023583A2 p53 BINDING AREAS |
| 04/27/2000 | WO2000023581A1 Dual reporter system and methods of use therefor |
| 04/27/2000 | WO2000023576A2 Secretases related to alzheimer's dementia |
| 04/27/2000 | WO2000023572A1 Tnfr related gene 12 |
| 04/27/2000 | WO2000023569A1 Surfactant protein d for the prevention and diagnosis of pulmonary emphysema |
| 04/27/2000 | WO2000023565A2 Novel neuropilin/growth factor binding and uses thereof |
| 04/27/2000 | WO2000023466A2 Human rna binding proteins |
| 04/27/2000 | WO2000023465A2 Methods and reagents for isolating biologically active peptides |
| 04/27/2000 | WO2000023464A2 Zinc finger binding domains for gnn |
| 04/27/2000 | WO2000023113A1 Peptide-based carrier devices for stellate cells |
| 04/27/2000 | WO2000023111A1 Method of diagnosing, monitoring, staging, imaging and treating prostate cancer |
| 04/27/2000 | WO2000023100A2 Genes and proteins predictive and therapeutic for renal disease and associated disorders |
| 04/27/2000 | WO2000023091A2 Specific therapeutic interventions obtained by interference with redistribution and/or targeting of cyclic nucleotide phosphodiesterases of i-kappa-b kinases |
| 04/27/2000 | WO2000023053A2 Artificial antigen-specific cells and related methods |
| 04/27/2000 | WO2000008149A3 Human neuronal acid-sensitive cationic channels, its cloning and applications |
| 04/27/2000 | WO2000007014A3 Leptin-mediated gene-induction |
| 04/27/2000 | WO2000006742A3 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 04/27/2000 | WO2000005407A3 DUPLICATIONS OF HUMAN CHROMOSOME 15q24-25 AND ANXIETY DISORDERS, DIAGNOSTIC METHODS FOR THEIR DETECTION |
| 04/27/2000 | WO2000005386A3 Chorismate biosynthesis enzymes |
| 04/27/2000 | WO2000005265A3 Anti-crr2 antibodies and methods of use therefor |
| 04/27/2000 | WO2000004152A3 Androgen receptor coactivators |
| 04/27/2000 | WO2000003034A3 Novel polycyclic aromatic fluorogenic substrates for hydrolases |
| 04/27/2000 | WO2000000636A3 In vivo determination of metabolic function for use in therapy management |
| 04/27/2000 | WO1999067416A3 METHOD FOR DETERMINING ANTIBIOTICS WITH β-LACTAM CORE IN A BIOLOGICAL FLUID |
| 04/27/2000 | WO1999064586A3 Phagocytic assay method |
| 04/27/2000 | WO1999063112A8 Pcr techniques for detecting microbial and viral contaminants in foodstuffs |
| 04/27/2000 | WO1999061596A3 Novel post-transcriptional regulatory elements and uses thereof |
| 04/27/2000 | WO1999057271A9 Feline cd80, feline cd86, feline cd28, and feline ctla-4 nucleic acid and polypeptides |
| 04/27/2000 | WO1999055844A3 Methods for modulating differentiation |
| 04/27/2000 | WO1999045357A3 Biosensor array comprising cell populations confined to microcavities |
| 04/27/2000 | WO1998056811A8 Plant grab proteins |
| 04/27/2000 | DE19950823A1 Quantitative determination of a target nucleic acid in a biological sample comprises amplification using a known number of labeled primer molecules |
| 04/27/2000 | DE19940752A1 Use of an illumination matrix that can be controlled to generate a freely adjustable illumination pattern to produce a microchip |
| 04/27/2000 | DE19849348A1 Identification and/or sequencing of an unknown DNA or RNA sequence adjacent to a known DNA or RNA region comprises linker-mediated PCR following amplification by linear PCR |
| 04/27/2000 | DE19849073A1 Transgene encoding amyloid precursor protein or its fragment, used to produce transgenic nematodes used, e.g. to screen for agents for treating Alzheimer's disease |
| 04/27/2000 | DE19849044A1 New polycythemia rubra vera-related polypeptide useful for diagnosis and for developing therapeutic antibodies |
| 04/27/2000 | DE19848665A1 New primers and probes from the factor V gene, useful for detecting the mutation that causes activated protein C resistance |
| 04/27/2000 | DE19848403A1 Exponential amplification of molecular matrices, useful for chemical evolution of e.g. peptides or nucleic acids, by synthesizing copies of immobilized matrices |
| 04/27/2000 | DE19842863A1 Regulatorisches Protein aus humanen Keratinozyten Regulatory protein from human keratinocytes |
| 04/27/2000 | CA2749553A1 Surfactant protein d for the prevention and diagnosis of pulmonary emphysema |
| 04/27/2000 | CA2388660A1 Secretases related to alzheimer's dementia |
| 04/27/2000 | CA2348156A1 Human proteins involved in endoplasmic reticulum protein degradation |
| 04/27/2000 | CA2347849A1 Omp85 proteins of neisseria gonorrhoeae and neisseria meningitidis, compositions containing same and methods of use thereof |
| 04/27/2000 | CA2347654A1 Human rna binding proteins |
| 04/27/2000 | CA2347625A1 Genes and proteins predictive and therapeutic for renal disease and associated disorders |
| 04/27/2000 | CA2347450A1 P53 binding areas |
| 04/27/2000 | CA2347103A1 Enzymatic methods for measuring lysophospholipids and phospholipids and correlation with diseases |
| 04/27/2000 | CA2347081A1 Method of diagnosing, monitoring, staging, imaging and treating prostate cancer |
| 04/27/2000 | CA2347080A1 Tnfr related gene 12 |
| 04/27/2000 | CA2347004A1 Methods of concentrating microorganisms using affinity separation |
| 04/27/2000 | CA2346937A1 Specific therapeutic interventions obtained by interference with redistribution and/or targeting |
| 04/27/2000 | CA2346798A1 Novel neuropilin/growth factor binding and uses thereof |
| 04/27/2000 | CA2346500A1 Methods and reagents for isolating biologically active peptides |
| 04/27/2000 | CA2345938A1 Polymorphism in a tgf-beta gene correlated to osteoporosis |
| 04/27/2000 | CA2344625A1 Methods for manipulating complex nucleic acid populations using peptide-labeled oligonucleotides |
| 04/27/2000 | CA2344605A1 G-protein coupled receptors |
| 04/27/2000 | CA2343974A1 Materials and methods involving conditional aggregation domains |
| 04/26/2000 | EP0995804A2 Nucleic acid analysis using complete N-mer arrays |
| 04/26/2000 | EP0995803A2 Sample treating kit and sample treating method using the same for analysis with a biosensor |
| 04/26/2000 | EP0995800A1 Probes for the diagnosis of infections caused by bacteroides fragilis |
| 04/26/2000 | EP0995798A1 Transcription factor of MHC class II genes, substances capable of inhibiting this new transcription factor and medical uses of these substances |
| 04/26/2000 | EP0995797A1 Methods for detecting and isolating nuclear transport proteins |
| 04/26/2000 | EP0995759A1 Angiopoietin related gene sequence scarface 2 |
| 04/26/2000 | EP0995445A2 Ligand-mediated immunofunctional hormone binding protein assay method |
| 04/26/2000 | EP0995120A1 Protein elongation factor 2 as a target for antifungal and antiparasitic agents |
| 04/26/2000 | EP0995118A1 Chaperone fragments |
| 04/26/2000 | EP0994970A1 Labelling composition and method |
| 04/26/2000 | EP0994969A1 Categorising nucleic acid |
| 04/26/2000 | EP0994968A1 Characterising nucleic acid |
| 04/26/2000 | EP0994967A1 Categorising nucleic acid |
| 04/26/2000 | EP0994966A1 Member of the tnf family useful for treatment and diagnosis of disease |
| 04/26/2000 | EP0994965A2 Taqman?tm -pcr for the detection of pathogenic e. coli strains |
| 04/26/2000 | EP0994964A1 Detection of nuceic acids by multiple sequential invasive cleavages |
| 04/26/2000 | EP0994963A1 Non-invasive prenatal diagnosis |
| 04/26/2000 | EP0994962A1 An indexed library of cells containing genomic modifications and methods of making and utilizing the same |
| 04/26/2000 | EP0994960A1 Methods for the detection of multiple single nucleotide polymorphisms in a single reaction |
| 04/26/2000 | EP0994951A1 Polynucleotides and their use for detecting resistance to streptogramin a or to streptogramin b and related compounds |
| 04/26/2000 | EP0994946A1 Coding sequence haplotypes of the human brca2 gene |
| 04/26/2000 | EP0994945A2 Smad-interacting polypeptides and their use |
| 04/26/2000 | EP0994899A2 5' ESTs FOR SECRETED PROTEINS EXPRESSED IN ENDODERM |
| 04/26/2000 | EP0994898A1 Integrin binding peptide and use thereof |
| 04/26/2000 | EP0994724A1 Methods and compositions for impairing multiplication of hiv-1 |
| 04/26/2000 | EP0973938A4 The use of nadph and nadh analogs in the measurement of enzyme activities and metabolites |
| 04/26/2000 | EP0972085A4 Sensors for electrically sensing binding events for supported molecular receptors |
| 04/26/2000 | EP0944820A4 Multi-array, multi-specific electrochemiluminescent testing |
| 04/26/2000 | EP0873417A4 Compositions for the detection of proteases in biological samples and methods of use thereof |